Atalanta Ghosh

Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion

David Polidori, Sue Sha, Sunder Mudaliar et al. · Diabetes Care · 2013 · 263 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes

Kenneth Cusi, Fernando Bril, Diana Barb et al. · Diabetes Obesity and Metabolism · 2018 · 197 citations

Medicine, Endocrinology, Pharmacology +17

Validation of a Novel Method for Determining the Renal Threshold for Glucose Excretion in Untreated and Canagliflozin-treated Subjects With Type 2 Diabetes Mellitus

David Polidori, Sue Sha, Atalanta Ghosh et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 87 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients

Jane E. Latz, Ajai K. Chaudhary, Atalanta Ghosh et al. · Cancer Chemotherapy and Pharmacology · 2005 · 84 citations

Medicine, Oncology, Pharmacokinetics +13

A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy

Jane E. Latz, Mats O. Karlsson, James J. Rusthoven et al. · Cancer Chemotherapy and Pharmacology · 2005 · 58 citations

Pharmacy, Pharmacokinetics, Pharmacology +11